Amazon Q Developer is a useful AI-powered coding assistant with chat, CLI, Model Context Protocol and agent support, and AWS ...

Gunmen abducted 303 schoolchildren and 12 teachers from St. Mary’s School in Niger state, Nigeria, according to an updated tally issued Saturday by the Christian Association of Nigeria ABUJA, Nigeria ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top of ...

Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...

Despite the 20 years between them and just under a year of knowing each other, Nichole McGruder, 43, and Chloe Denning, 19, talk more like friends than a counselor and client. But, as McGruder says, ...

Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. RXRX's AI-driven drug discovery model is ambitious, but pipeline value ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...

In an age of constant communication, receiving phone calls or messages from unknown numbers has become increasingly common. Whether it's a missed call from an unfamiliar number, a potential scam or a ...

The adoption of artificial intelligence (AI) in U.S. classrooms has accelerated rapidly over the past year, with double-digit growth in the number of students using AI tools for schoolwork, according ...

The Pentagon has signed on to use Grok, the AI chatbot built by Elon Musk's company xAI, as part of a new $200 million agreement that opens the door for its deployment across the federal government, ...

Our phones are a direct line to us, but sometimes we don’t want to give our numbers out to just anyone. They have more information attached to them than we might realize. Instead of giving your real ...

Recursion, a clinical-stage TechBio company, has successfully acquired Rallybio’s entire interest in their joint ENPP1 inhibitor program (REV102) aimed at treating hypophosphatasia (HPP), a rare ...